🇺🇸 FDA

Intelligence Platform

Patents

Browse 302 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7244844

Reference standard for characterization of rosuvastatin

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jul 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7235691

Crystalline forms of modafinil

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 26 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 21 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7196222

Sertraline hydrochloride form II and methods for the preparation thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7195778

Drug delivery system for zero order, zero order-biphasic, ascending or descending drug del

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7192588

Vaccine composition and method of using the same

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7189861

Processes for preparing amorphous atorvastatin hemi-calcium

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7183272

Crystal forms of oxcarbazepine and processes for their preparation

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Feb 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7161012

Processes for preparing amorphous atorvastatin hemi-calcium

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jan 09 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7151183

Processes for preparing amorphous atorvastatin hemi-calcium

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7148376

Polymorphic forms of nateglinide

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7144916

Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7138137

Stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparatio

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 21 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7129358

Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1H-benzimidazoles

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 31 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7126008

Carvedilol

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 24 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7122681

Desolvation process for the production of atorvastatin hemi-calcium essentially free of bo

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 17 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7060837

Method for the purification of lansoprazole

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 13 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7056942

Carvedilol

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 06 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7038060

Synthesis of 2-butyl-3-(2′-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-yl)-1,3-diazaspiro[4.4]-n

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue May 02 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 7033582

Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorde

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Apr 25 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 7022859

Method for the purification of lansoprazole

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Apr 04 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 7022881

Sertraline hydrochloride polymorphs

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Apr 04 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6992194

Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jan 31 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6987175

Processes for preparing clarithromycin polymorphs

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jan 17 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6956060

Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 18 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired